European Child & Adolescent Psychiatry

, Volume 15, Issue 3, pp 149–155 | Cite as

Substance use and depression. Comparative course in adolescents

  • Léonie Chinet
  • Bernard Plancherel
  • Monique Bolognini
  • Mathieu Bernard
  • Jacques Laget
  • Giusi Daniele
  • Olivier Halfon



To examine the relation between depression and substance use in adolescents and the concomitant courses of both disorders.


Four individual interviews were administered to 85 adolescent substance users aged 14–19 years (mean 17.1 years, SD 1.4) over a 3.5 year period using the Adolescent Drug Abuse Interview (ADAD) and the Beck Depression Inventory (BDI-13).


No predictive effect was observed on one dimension over the other, but each dimension was predictive of its own course. A decrease in substance-use severity paralleled a decrease in depressive state. Similarly, stable substance-use rates, either at a low or a high level, tended to be associated with low or high levels of depression, respectively. However, an increase in substance use was not accompanied by an increase in depressive states. Moreover, depression varied greatly between adolescents, and according to gender and age.


Depressive states and substance use in adolescents can vary considerably overtime, and are closely but rather synchronically related. Since most of the adolescents do not seek help for substance-related problems, substance use should be systematically assessed in adolescents presenting with a depressive state.


adolescent substance use depression longitudinal design community study 



This study was supported by a research grant from the Swiss Federal Office of Public Health, ref. 316.98.8108.


  1. 1.
    Arbuckle JL (1989) Amos: Analysis of moment structures. Am Stat 43:66–67Google Scholar
  2. 2.
    Armstrong TD, Costello EJ (2002) Community studies on adolescent substance use, abuse, or dependence and psychiatric comorbidity. J Consult Clin Psychol 70:1224–1239 [Review]PubMedGoogle Scholar
  3. 3.
    Beck AT, Beamesderfer A (1974) Assessment of depression: the depression inventory. Mod Probl Pharmacopsychiatry 7:151–169PubMedGoogle Scholar
  4. 4.
    Bolognini M, Plancherel B, Laget J, Chinet L, Rossier V, Cascone P, Stéphan P, Halfon O (2001) Evaluation of the Adolescent Drug Abuse Diagnosis instrument in a Swiss sample of drug abusers. Addiction 96:1477–1484CrossRefPubMedGoogle Scholar
  5. 5.
    Brook DW, Brook JS, Zhang CS, Cohen P, Whiteman M (2002) Drug use and the risk of major depressive disorder, alcohol dependence, and substance use disorders. Arch Gen Psychiatry 59: 1039–1044PubMedGoogle Scholar
  6. 6.
    Brook JS, Cohen P, Brook DW (1998) Longitudinal study of co-occurring psychiatric disorders and substance use. J Am Acad Child Adolesc Psychiatry 37:322–330PubMedGoogle Scholar
  7. 7.
    Chander G, McCaul ME (2003) Co-occurring psychiatric disorders in women with addictions. Obstet Gynecol Clin North Am 30:469–481CrossRefPubMedGoogle Scholar
  8. 8.
    Collet L, Cottraux J (1986) [The shortened Beck depression inventory, (13 items). Study of the concurrent validity with the Hamilton scale and Widlocher’s retardation scale]. Encephale 12:77–79 [French]PubMedGoogle Scholar
  9. 9.
    Costello EJ, Erkanli A, Federman E, Angold A (1999) Development of psychiatric comorbidity with substance abuse in adolescents: effects of timing and sex. J Clin Child Psychol 28:298–311CrossRefPubMedGoogle Scholar
  10. 10.
    Degenhardt LH (2003) Exploring the association between cannabis use and depression. Addiction 98:1493–1504PubMedGoogle Scholar
  11. 11.
    Enns MW, Swenson JR, McIntyre RS, Swinson RP, Kennedy SH (2001) Clinical guidelines for the treatment of depressive disorders VII. Comorbidity. Can J Psychiatry-Revue Canadienne de Psychiatrie 46:77S–90SGoogle Scholar
  12. 12.
    Friedman AS, Bransfield S, Kreisher C (1994) Early teenage substance use as a predictor of educational-vocational failure. Am J Addict 3:325–336Google Scholar
  13. 13.
    Giaconia RM, Reinherz HZ, Paradis AD, Hauf AM, Stashwick CK (2001) Major depression and drug disorders in adolescence: general and specific impairments in early adulthood. J Am Acad Child Adolesc Psychiatry 40:1426–1433PubMedGoogle Scholar
  14. 14.
    Grella CE, Hser YI, Joshi V, Rounds-Bryant J (2001) Drug treatment outcomes for adolescents with comorbid mental and substance use disorders. J Nerv Ment Dis 189:384–392CrossRefPubMedGoogle Scholar
  15. 15.
    ISPA (Institut suisse de prévention de l’alcoolisme et autres toxicomanies) (2001) Alcool, tabac et cannabis dans la réalité quotidienne des 12–15 ans. Sélection de résultats d’une enquête menée sous l’égide de l’OMS avec le soutien financier de l’OFSP. ISPA, LausanneGoogle Scholar
  16. 16.
    ISPA (Institut suisse de prévention de l’alcoolisme et autres toxicomanies) (2003) Chiffres et données 2003. ISPA, LausanneGoogle Scholar
  17. 17.
    Kandel DB, Davies M, Karus D, Yamaguchi K (1986) The consequences in young adulthood of adolescent drug involvement. An overview. Arch Gen Psychiatry 43:746–754PubMedGoogle Scholar
  18. 18.
    Kandel DB, Huang FY, Davies M (2001) Comorbidity between patterns of substance use dependence and psychiatric syndromes. Drug Alcohol Depend 64:233–241PubMedGoogle Scholar
  19. 19.
    Kandel DB, Johnson JG, Bird HR, Weissman MM, Goodman SH, Lahey BB (1999) Psychiatric comorbidity among adolescents with substance use disorders: Findings from the MECA study. J Am Acad Child Adolesc Psychiatry 38:693–699PubMedGoogle Scholar
  20. 20.
    Kessler RC, Nelson CB, McGonagle KA, Edlund MJ, Frank RG, Leaf PJ (1996) The epidemiology of co-occurring addictive and mental disorders: Implications for prevention and service utilization. Am J Orthopsychiatry 66:17–31PubMedGoogle Scholar
  21. 21.
    Lynskey MT, Coffey C, Degenhardt L, Carlin JB, Patton G (2003) A longitudinal study of the effects of adolescent cannabis use on high school completion. Addiction 98:685–692CrossRefPubMedGoogle Scholar
  22. 22.
    Milin R, Walker S, Chow J (2003) Major depressive disorder in adolescence: a brief review of the recent treatment literature. Can J Psychiatry 48:600–606 [Review]PubMedGoogle Scholar
  23. 23.
    Mueser KT, Drake RE, Wallach MA (1998) Dual diagnosis: a review of etiological theories. Addict Behav 23:717–734 [Review]CrossRefPubMedGoogle Scholar
  24. 24.
    Narring F, Tschumper A, Inderwildi Bonivento L, Jeannin A, Addor V, Bütikofer A (2003) Santé et styles de vie des adolescents âgés de 16 à 20 ans en Suisse, (2002). SMASH 2002: Swiss Multicenter Adolescent Study on Health 2002. Institut Universitaire de Médecine Sociale et Préventive LausanneGoogle Scholar
  25. 25.
    Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 20(59):22–33 [Review]Google Scholar
  26. 26.
    Thorpe L, Whitney DK, Kutcher SP, Kennedy SH (2001) Clinical guidelines for the treatment of depressive disorders VI. Special populations. Can J Psychiatry 46:63S–76SPubMedGoogle Scholar
  27. 27.
    Wills TA, Vaccaro D, McNamara G, Hirky AE (1996) Escalated substance use: a longitudinal grouping analysis from early to middle adolescence. J Abnorm Psychol 105:166–180CrossRefPubMedGoogle Scholar
  28. 28.
    Zilberman ML, Tavares H, Blume SB, el Guebaly N (2003) Substance use disorders: Sex differences and psychiatric comorbidities. Can J Psychiatry 48:5–13PubMedGoogle Scholar

Copyright information

© Steinkopff Verlag Darmstadt 2006

Authors and Affiliations

  • Léonie Chinet
    • 1
  • Bernard Plancherel
    • 1
  • Monique Bolognini
    • 1
  • Mathieu Bernard
    • 1
  • Jacques Laget
    • 1
  • Giusi Daniele
    • 1
  • Olivier Halfon
    • 1
  1. 1.SUPEA Research UnitUniversity Child and Adolescent Psychiatric Clinic, University of LausanneLausanneSwitzerland

Personalised recommendations